Reprieve is a medical technology company developing a diuretic treatment device for acute decompensated heart failure (ADHF) patients.
reprievecardio.com
Milford, MA
CEO: Mark Pacyna
Arboretum Lead: Jan Garfinkle
Reprieve Cardiovascular
IN THE NEWS
Reprieve Cardiovascular Partners with Leading Heart Failure Researchers and Truveta to Analyze Real-World Heart Failure Patient Data
Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart…
Read More
Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing
Reprieve Cardiovascular, Inc., a development stage company focused on pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart failure (ADHF) treatment, today announced it has raised…
Read More
